Target type: biologicalprocess
The process in which the release of sequestered calcium ion by sarcoplasmic reticulum into cytosol occurs via calcium release channels. [GOC:mtg_muscle]
The release of sequestered calcium ions into the cytosol by the sarcoplasmic reticulum (SR) is a fundamental process in muscle contraction. Here's a detailed description:
1. **Action Potential Arrival:** The process begins with an action potential arriving at the neuromuscular junction, triggering the release of acetylcholine.
2. **Depolarization of T-Tubules:** Acetylcholine binds to receptors on the muscle fiber membrane, causing depolarization. This depolarization spreads down the transverse tubules (T-tubules), which are invaginations of the plasma membrane.
3. **Activation of Dihydropyridine Receptors:** Depolarization of the T-tubules activates dihydropyridine receptors (DHPRs) located within the T-tubules. These receptors are physically linked to ryanodine receptors (RyRs) on the SR membrane.
4. **Conformational Change in RyRs:** The activation of DHPRs causes a conformational change in RyRs. This change opens the RyR channels, allowing calcium ions to flow out of the SR and into the cytosol.
5. **Calcium Ion Release:** The SR is a specialized intracellular organelle that stores large amounts of calcium ions. When RyRs open, these ions rapidly diffuse out of the SR, driven by a concentration gradient.
6. **Calcium Ion Binding to Troponin:** The released calcium ions bind to troponin, a protein complex associated with thin filaments (actin) in the muscle fiber. This binding triggers a conformational change in troponin, moving tropomyosin away from the actin binding sites.
7. **Muscle Contraction:** The removal of tropomyosin from the actin binding sites allows myosin heads to bind to actin, initiating the cross-bridge cycle and muscle contraction.
8. **Calcium Ion Reuptake:** After contraction, calcium ions are actively pumped back into the SR by the SR Ca2+ ATPase (SERCA) pump. This reuptake lowers the cytosolic calcium concentration, allowing the muscle to relax.
9. **Regulation of Calcium Release:** The release of calcium from the SR is tightly regulated. The DHPR-RyR coupling ensures that calcium release occurs only when the muscle fiber is depolarized. Additionally, other regulatory proteins, such as calmodulin and phospholamban, can influence the activity of RyRs and SERCA pumps.
In summary, the release of sequestered calcium ions from the SR is a crucial step in muscle contraction, triggering the interaction between actin and myosin, leading to muscle fiber shortening. This process is highly regulated, ensuring efficient and coordinated muscle function.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ryanodine receptor 2 | A ryanodine receptor 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92736] | Homo sapiens (human) |
C-C chemokine receptor type 5 | A C-C chemokine receptor type 5 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P51681] | Homo sapiens (human) |
Ryanodine receptor 1 | A ryanodine receptor 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P21817] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
1,10-phenanthroline | 1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases | phenanthroline | EC 2.7.1.1 (hexokinase) inhibitor; EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor |
2,2'-dipyridyl | 2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'. 2,2'-Dipyridyl: A reagent used for the determination of iron. | bipyridine | chelator; ferroptosis inhibitor |
disulfiram | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor | |
nevirapine | nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection. Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS. | cyclopropanes; dipyridodiazepine | antiviral drug; HIV-1 reverse transcriptase inhibitor |
terfenadine | Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME. | diarylmethane | |
4,4'-dimethyl-2,2'-bipyridine | 4,4'-dimethyl-2,2'-bipyridine: structure in first source | ||
5,5'-dimethyl-2,2'-bipyridyl | 5,5'-dimethyl-2,2'-bipyridyl: structure in first source | bipyridines | |
neocuproine | neocuproine : A member of the class of phenanthrolines that is 1,10-phenanthroline bearing two methyl substituents at positions 2 and 9. neocuproine: Spectrophotometric determination of copper and ultramicro blood sugar determinations; structure; RN given refers to parent cpd | phenanthrolines | chelator; copper chelator |
2,2',2''-terpyridine | 2,2',2''-terpyridine: RN given refers to parent cpd 2,2':6',2''-terpyridine : A tridentate heterocyclic ligand that binds metals at three meridional sites giving two adjacent 5-membered MN2C2 chelate rings. | terpyridines | chelator |
5-methyl-1,10-phenanthroline | |||
3,4,7,8-tetramethyl-1,10-phenanthroline | |||
tak 779 | |||
aplaviroc | aplaviroc: a spiro-diketo-piperazine; a potent noncompetitive allosteric antagonist of the CCR5 receptor with concomitantly potent antiviral effects for HIV-1; structure in first source | ||
maraviroc | tropane alkaloid | ||
vicriviroc | vicriviroc: structure in first source | (trifluoromethyl)benzenes | |
tak-220 | TAK-220: structure in first source | ||
cp 481715 | quinoxaline-2-carboxylic acid (4-carbamoyl-1-(3-fluorobenzyl)-2,7-dihydroxy-7-methyloctyl)amide: a CCR1 antagonist and NSAID; structure in first source | ||
ancriviroc | Ancriviroc: CCR5 receptor antagonist | aromatic carboxylic acid; pyridinemonocarboxylic acid | |
variecolin | variecolin: structure in first source | enal; sesterterpenoid | Aspergillus metabolite |
ucb 35625 | UCB 35625: J-113863 is the (trans)-isomer; structure in first source | ||
bastadin 5 | |||
bastadin 4 | |||
amd 070 | mavorixafor: a derivative of AMD3100; a CXCR4 blocker | aminoquinoline | |
chlorantranilipole | chlorantranilipole: anthranilic diamide insecticide.that disrupts mating in codling moth (Lepidoptera: Tortricidae) chlorantraniliprole : A carboxamide resulting from the formal condensation of the carboxylic acid group of 3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid with the primary amino group of 2-amino-5-chloro-N,3-dimethylbenzamide. The first of the anthranilic diamide insecticides, it is a ryanodine receptor activator and is used to protect a wide variety of crops, including corn, cotton, grapes, rice and potatoes. | monochlorobenzenes; organobromine compound; pyrazole insecticide; pyrazoles; pyridines; secondary carboxamide | ryanodine receptor agonist |
cenicriviroc | cenicriviroc : A member of the class of benzazocines that is (5Z)-1,2,3,4-tetrahydro-1-benzazocine which is substituted by a 2-methylpropyl, N-{4-[(S)-(1-propyl-1H-imidazol-5-yl)methanesulfinyl]phenyl}carboxamide and 4-(2-butoxyethoxy)phenyl groups at positions 1, 5 and 8, respectively. It is a potent chemokine 2 and 5 receptor antagonist currently in development for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis (NASH). cenicriviroc: an inhibitor of HIV-1 | aromatic ether; benzazocine; diether; imidazoles; secondary carboxamide; sulfoxide | anti-HIV agent; anti-inflammatory agent; antirheumatic drug; chemokine receptor 2 antagonist; chemokine receptor 5 antagonist |
19,20-epoxycytochalasin q | 19,20-epoxycytochalasin Q: from Xylaria sp.; structure in first source | ||
fuscin | fuscin: antibacterial pigment produced by the fungus Didiodendron fuscom; minor descriptor (75-82); online & Index Medicus search BENZOPYRANS (75-82) |